Skip to main content

Table 1 The expression and clinical characteristics of MAFG-AS1 in cancers

From: LncRNA MAFG-AS1 is involved in human cancer progression

Disease type

Expression

Clinical characteristics

Refs.

Breast cancer

Upregulated

Tumor size, and ki-67

[43,44,45,46,47,48,49]

Lung cancer

Upregulated

OS

[50,51,52]

Liver cancer

Upregulated

OS

[53,54,55,56,57,58]

Bladder cancer

Upregulated

DFS, OS, clinical stages, and TMN stages

[59,60,61,62,63]

Colorectal cancer

Upregulated

Depth of invasion, TNM stage, OS, and DFS

[64,65,66]

Gastric cancer

Upregulated

Clinical stage, depth of invasion, lymph node metastasis, distant metastasis, and OS

[67, 68]

Esophageal cancer

Upregulated

OS

[69]

Prostate cancer

Upregulated

–

[70]

Pancreatic cancer

Upregulated

–

[71]

Ovarian cancer

Upregulated

Tumor stage, size, lymph node metastasis, and OS

[72]

Glioma

Upregulated

–

[73]